RPS12P22: A Protein Targeted for Therapeutic Applications (G440055)

Target Name: RPS12P22

NCBI ID: G440055

RPS12P22

Other Name(s): RPS12_10_1156 | Ribosomal protein S12 pseudogene 22 | ribosomal protein S12 pseudogene 22

RPS12P22: A Protein Targeted for Therapeutic Applications

RPS12P22 is a protein that is expressed in various tissues of the body, including the brain, heart, and gastrointestinal tract. It is a member of the RPS12 gene family, which encodes a protein involved in the regulation of mitochondrial dynamics. The function of RPS12P22 is not well understood, but it is known to play a role in the regulation of mitochondrial function and has been implicated in a number of diseases, including cancer, neurodegenerative diseases, and obesity.

Drug Targeting

One of the primary goals of drug development is to identify compounds that can modulate the activity of a protein and improve its function, or inhibit its activity and reduce its function. RPS12P22 is a potential drug target, and a number of studies have explored its potential as a therapeutic agent.

One approach to identifying drug targets is to use a computational screen to identify potential binding partners of the protein. This approach has been used to identify potential binding partners for RPS12P22 and has led to the identification of small molecules that have been shown to interact with the protein.

Another approach to identifying drug targets is to use structural bioinformatics to predict the binding site of small molecules. This approach has been used to predict the binding site of small molecules for RPS12P22 and has led to the identification of a number of potential binding sites.

Another approach is to use gene editing to modify the RPS12P22 gene and create a modified protein that can be used as a drug target. This approach has been used to create a number of modified proteins that have been shown to interact with RPS12P22 and have the potential to be used as drug targets.

Mechanism of Action

The exact mechanism of action of RPS12P22 is not well understood, but it is known to play a role in the regulation of mitochondrial dynamics. Mitochondria are organelles that are responsible for generating energy for the cell through a process called cellular respiration. They are also involved in the regulation of a number of cellular processes, including metabolism, energy homeostasis, and stress response.

RPS12P22 is a protein that is involved in the regulation of mitochondrial dynamics and has been shown to play a role in the regulation of cellular respiration. It is known to interact with the inner mitochondrial membrane and is involved in the regulation of the movement of mitochondrial proteins into the cytoplasm.

In addition, RPS12P22 is also known to play a role in the regulation of the citric acid cycle, a process that is involved in the production of energy in the cell. It is known to interact with the protein known as Complex I, which is involved in the citric acid cycle and is a key regulator of this process.

Potential Therapeutic Applications

RPS12P22 is a protein that is involved in the regulation of mitochondrial dynamics and has the potential to be used as a drug target in a number of ways.

One potential therapeutic application of RPS12P22 is as a treatment for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. These conditions are characterized by the progressive loss of brain cells and can be treated with a variety of medications, but there is a need for new and effective treatments.

Another potential therapeutic application of RPS12P22 is as a treatment for cancer. Many cancer treatments involve the inhibition of mitochondrial function, and RPS12P22 may be a useful target for cancer treatments.

RPS12P22 has also

Protein Name: Ribosomal Protein S12 Pseudogene 22

The "RPS12P22 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RPS12P22 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets